The Cyp7a1/Cyp27a1 classical pathway is responsible for the synthesis of BA species that protect against NAFLD while the 12-hydroxylated BA species formed via the Cyp8b1 pathway have been associated with metabolic impairments30. Here, CYP8B1 is linked to metabolic dysfunction-associated steatotic liver disease.